Polypeptides, their production and use
View Patent ↗The present invention relates to the ligand polypeptide for the human pituitary- and mouse pancreas-derived G protein-coupled receptor proteins. The ligand polypeptide or the DNA which codes for the ligand polypeptide can be used for (1) development of medicines such as pituitary function modulators, central nervious system function modulators, and pancreatic function modulators, and (2) development of receptor binding assay systems using the expression of recombinant receptor proteins and screening of pharmaceutical candidate compounds. In particular, by the receptor binding assay systems utilizing the expression of recombinant G protein-coupled receptor proteins in accordance with the invention, agonists and antagonists of G protein-coupled receptors which are specific to human and other warm-blooded animals can be screened and the agonists or antagonists obtained can be used as therapeutic and prophylactic agents for various diseases.
1. A screening method for a compound capable of changing the binding activity of a ligand polypeptide comprising the amino acid sequence of SEQ ID NO: 73, or its amide or ester, or a salt thereof, or a partial peptide of said ligand polypeptide, or its amide or ester, or a salt thereof, with a receptor protein comprising the amino acid sequence of SEQ ID NO:21; SEQ ID NO:22, or a salt thereof, or a partial peptide of said receptor protein, or a salt thereof, the method comprising making a comparison of said binding activity between:
(i) at least one case where said ligand polypeptide, or its amide or ester, or a salt thereof, or a partial peptide of said ligand polypeptide, or its amide or ester, or a salt thereof is contacted with said receptor protein or a salt thereof or a partial peptide of said receptor protein, or a salt thereof, and
(ii) at least one case where said ligand polypeptide or its amide or ester, or a salt thereof, or a partial peptide of said ligand polypeptide, or its amide or ester, or a salt thereof together with a sample containing the compound to be tested is contacted with the receptor protein or a salt thereof or a partial peptide of said receptor protein or a salt thereof.
2. The method as claimed in claim 1 , wherein the ligand polypeptide comprises the amino acid sequence of SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO: 47, SEQ ID NO:48, SEQ ID NO:49, SEQ ID NO:50, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO: 61, SEQ ID NO:62, SEQ ID NO:63, SEQ ID NO:64, SEQ ID NO:65, or SEQ ID NO:66.
3. The method as claimed in claim 1 , wherein the ligand polypeptide comprises the amino acid seqeunece of SEQ ID NO:1, SEQ ID NO:44, SEQ ID NO:45, or SEQ ID NO:59.
4. The method as claimed in claim 1 , wherein the receptor protein comprises the amino acid sequence of SEQ ID NO:21.